Skip to main content

Table 2 Changes in the Exercise on Prescription and the Control group

From: The effect of exercise on prescription on physical activity and wellbeing in a multi-ethnic female population: A controlled trial

  EoP group intercept Δ 6 months Δ 12 months Control group Δ 6 months Δ 12 months Δ change 6 months between groups Δ change 12 months between groups
Physical activity         
 Total score 3147 (2473, 3822) 285 (−305, 875) −88 (−660, 485) 4508 (3898, 5118) 108 (−466, 681) −430 (−1025, 166) 177 (−646, 1001) 342 (−485, 342)
 Leisure time score 854 (647, 1062) 65 (−155, 285) 46 (−168, 261) 1296 (1143, 1449) −251 (−412, -89)* −386 (−556, -215)* 316 (43, 589)* 432 (158, 706)*
 Household score 2123 (1867, 2380) 118 (−110, 346) 258 (35, 482)* 2441 (2216, 2667) −22 (−238, 193) −54 (−279, 170) 140 (−174, 454) 312 (−4, 629)
 Work score 750 (237, 1261) −99 (−590, 390) −490 (−966, -13)* 815 (438, 1191) 250 (−108, 609) −191 (−571, 190) −350 (−957, 258) −299 (−909, 311)
 Commuting score 93 (54, 132) 60 (8, 111)* 7 (−43, 57)) 191 (150, 233) 12 (−38, 62) −41 (−93, 11) 48 (−24, 120) 48 (−24, 120)
VO2max (ml/kg/min) 23.8 (22.9, 24.7) 0.69 (−0.42, 1.81) 0.53 (−0.56, 1.62) 24.06 (23.3, 24.9) 0.73 (−0.18, 1.63) 0.35 (−0.56, 1.26) −0.03 (−1.47, 1.40) 0.18 (−1.24, 1.60)
BMI (kg/m2) 32.7 (31.5, 33.8) 0.37 (0.04, 0.70)* 0.28 (−0.03, 0.60) 31.4 (30.5, 32.4) −0.08 (−0.41, 0.26) 0.35 (0.03, 0.67)* 0.45 (−0.02, 0.92 ) −0.07 (−0.52, 0.39)
Fatpercentage (%) 39.5 (38.9, 40.0) −0.16 (−0.71, 0.38) 0.92 (0.40, 1.44)* 38.3 (37.8, 38.9 ) −0.11 (−0.66, 0.45) 0.24 (−0.30, 0.79) −0.06 (−0.83, 0.72) 0.67 (−0.08, 1.43)
Waistcircumference (cm) 96.2 (94.2, 98.1) −1.8 (−3.2, -0.37)* −2.06 (−3.42, -0.70)* 94.2 (92.3, 96.0) −1.49 (−2.8, -0.17) −1.29 (−2.6, -0.01) −0.31 (−2.27, 1.64) −0.77 (−2.64, 1.11)
Mental well-being 15.8 (14.1, 17.4) −0.06 (−1.07, 0.95) 0.35 (−0.62, 1.32) 19.5 (18.0, 20.9) 0.24 (−0.68, 1.16) −0.00 (−0.96, 0.96) −0.30 (−1.67, 1.07) 0.35(−1.01, 1.72)
  1. Table 2 Changes in the Exercise on Prescription and the Control Group. Δ 6 months: changes at 6 months compared to baseline, Δ 12 months: changes at 12 months compared to baseline. *; significant difference (P < 0.05).